CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-21 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −36,573 | $242.67 | $8.9M | 64,123 |
| 2026-01-21 | Sheena Jonathan Director | Sale 10b5-1 | −93 | $235.00 | $22K | 267,148 |
| 2026-01-21 | Sheena Jonathan Director | Sale 10b5-1 | −2,470 | $234.12 | $578K | 264,678 |
| 2026-01-21 | Sheena Jonathan Director | Sale 10b5-1 | −600 | $235.82 | $141K | 264,078 |
| 2026-01-20 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −17,806 | $234.74 | $4.2M | 177,591 |
| 2026-01-20 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −23,205 | $234.74 | $5.4M | 144,992 |
| 2026-01-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −19,234 | $234.74 | $4.5M | 226,615 |
| 2026-01-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Option exercise 10b5-1 | +856 | 227,471 | ||
| 2026-01-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Option exercise · Restricted Stock Unit 10b5-1 | −856 | 0 | ||
| 2026-01-20 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −71,932 | $234.74 | $16.9M | 217,354 |
| 2026-01-20 | Chapman Steven Leonard CEO AND PRESIDENT | Option exercise 10b5-1 | +3,386 | 220,740 | ||
| 2026-01-20 | Chapman Steven Leonard CEO AND PRESIDENT | Option exercise · Restricted Stock Unit 10b5-1 | −3,386 | 0 | ||
| 2026-01-20 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −23,948 | $234.74 | $5.6M | 99,776 |
| 2026-01-20 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +1,522 | 101,298 | ||
| 2026-01-20 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit 10b5-1 | −1,522 | 0 | ||
| 2026-01-20 | Sheena Jonathan Director | Sale 10b5-1 | −2,981 | $234.74 | $700K | 267,050 |
| 2026-01-20 | Sheena Jonathan Director | Option exercise 10b5-1 | +191 | 267,241 | ||
| 2026-01-20 | Sheena Jonathan Director | Option exercise · Restricted Stock Unit 10b5-1 | −191 | 0 | ||
| 2026-01-14 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Grant or award 10b5-1 | +44,698 | 195,397 | ||
| 2026-01-14 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Grant or award 10b5-1 | +44,698 | 168,197 |
Page 29 of 39 · 767 trades